myocardium in association with a left ventricular aneurysm. Pericardial calcification was found primarily over the right-sided cardiac chambers and in the atrioventricular grooves, infrequently over the base of the left ventricle, and rarely over the apex of the left ventricle. When the left ventricle was involved, there was always more extensive calcification elsewhere in the pericardium. Myocardial calcification occurred predominantly in the apex of the left ventricle, although it was rarely confined to the posterior wall of the left ventricle. Isolated calcification in the region of the left ventricular apex, therefore, strongly suggests left ventricular aneurysm. We present a 45 year old patient with old anterior wall myocardial infarction who had significant left ventricle wall calcification with no aneurysm. No calcium or parathyroid abnormalities could be detected in the patient after lab investigations. Metastatic calcification of various organs including myocardium has been reported with HTLV-1 infection, but in our case, HTLV-1 was negative. Myocardial calcification has been reported after orthotopic heart transplantations or unselected bone marrow transplantation to acute myocardial infarction in an animal model. Thus isolated idiopathic left ventricular calcification without any detectable abnormality was found to be worth reporting.
A case of Marfans syndrome with ascending and arch of aorta aneurysm presenting with type A-dissection of aorta E. Srikanth *, Ravi Srinivas, Adikesava Naidu, Y.V. Subba Reddy Cardiology Department, Osmania General Hospital, Hyderabad, India Introduction: Marfans syndrome is a hereditary disease which is autosomal dominant inheritance because of mutation in the fibrillin-1 gene, which effects connective tissue of the body, mainly involves cardiovascular system, ocular and skeletal system. It is usually diagnosed with 2010 Revised Ghent Nosology with a score of more 7. The cardiovascular manifestation includes aortic root and arch aneurysm with high risk of dissection (root diameter of >4.5 cm), mitral valve prolapse, aortic regurgitation secondary to root dilatation, skeletal abnormalities scoliosis, pectus excavatum, positive thumb & wrist sign, ectopia lens. Case report: A female 40 years old patient presented with chest pain retrosternal since 1 month, tearing type radiating neck and back of chest associated with breathlessness of class 3 on examination conscious and coherent pulse rate = 78/min felt in all limbs, blood pressure 150/60 mm of Hg, CVS S1 S2+, ESM 3/6 and EDM heard on 3rd left intercostal area, MDM at the apex. ECG was showing LV volume overload, on 2D echo evaluation was showing aorta root showing 4.78 cm with severe AR good LV function. Patient was evaluated with trans-esophageal echo, chest X ray and CECT was diagnosed as ascending and arch aneurysm with dissection of aorta type-A. Patient was referred to CT surgery dept for Benthal procedure. Discussion: The incidence of aortic dissection is estimated to be 2-3.5/10,000 persons per year and peak incidence at sixth and seventh decade with overall mortality 1%/h, patients with Marfans syndrome at higher risk can occur at younger age. It is classified into Debakey type 1,2,3 and Stanfords type A and B depending upon location of dissection. High clinical suspicion required for diagnosing dissection has variable clinical manifestation most common is chest pain (80%), severe aortic insufficiency (45%), hypotension (14%), shock (13%), syncope (12%), MI (7-19%), CVA (8%) and paraplegia (2%), pulse deficit is seen (26%). The management of the dissection is beta blocker drug of choice, followed by ACE inhibitors. Background of the study: To assess the ventricular dyssynchrony in VVI pacemaker patients and to find any difference in occurrence of ventricular dyssynchrony between sick sinus syndrome and complete heart block patients. Materials: Totally 16 patients who underwent VVI pacemaker were studied. The indications for permanent pacemaker implantation were complete heart block and sick sinus syndrome. Among 18 patients, 14 patients had diagnosis of complete heart block and 4 patients had sick sinus syndrome. The follow up assessment of ventricular dyssynchrony was done with a minimum period of one month and maximum period of 12 years after the VVI pacemaker implantation. Patients who had myocardial infarction, valvular heart disease, cardiomyopathies and regional wall motion abnormalities at the baseline were excluded from the study. Methods: All the 18 patients underwent 2D echo, Doppler, M-mode in the HD 7 Phillips echo machine for assessing the ventricular dyssynchrony, intraventricular dyssynchrony, interventricular dyssynchrony and atrioventricular dyssynchrony were assessed. Intraventricular dyssynchrony was defined if the septal to posterior wall delay is more than 130 ms. Interventricular dyssynchrony was diagnosed if the difference in pre-ejection time interval between two ventricles was more than 40 ms. Atrioventricular dyssynchrony was diagnosed if the ratio of left ventricular filling time to RR interval is less than 40%. Results: After the study, 6 patients with complete heart block had significant intraventricular dyssynchrony with septal to posterior wall delay of more than 130 ms. By comparing the results between complete heart block and sinus node dysfunction patients, none of the sinus node dysfunction patients developed intraventricular dyssynchrony. The intraventricular dyssynchrony is much prolonged, with the value of more than 155 ms in patients who underwent the VVI pacemaker 12 years back. None of the patients who underwent the study had interventricular and atrioventricular dyssynchrony. Conclusion: Following VVI pacemaker intraventricular dyssynchrony is common. But this study reveals intraventricular dyssynchrony is more common in complete heart block than sinus node dysfunction patients. The reason for intraventricular synchrony in sinus node dysfunction is not clear, even though both groups were paced from right ventricle.
Echocardiographic assessment of LV clot and its DDs 
cultural, ethnical and geographical differences. Cardiac embolic stroke is the leading pathology. Early detection and proper treatment will definitely reduce the socio economic burden. Echocardiography is the simplest non invasive tool for assessment. Conclusion/observation: Heart is a vital organ, which actively pumps the blood to all vital organs continuously. One of the important sources for CVA is intra cardiac thrombus in general and LV in particular. TTE is an excellent non invasive tool for assessment of gross appearance of thrombus and associated cardiac conditions. Predisposing factors are subendocardial injury, wall motion abnormality and hyper coagulable state of blood. All these factors can reasonably evaluated by Echo. Knowledge of presence of various non thrombotic conditions, normal variants and ultrasonic artifacts are essential to evaluate any differential diagnosis. Echo also helps in monitoring the size of the thrombus with respect to efficiency of medications provided and rule out its presence before any cath intervention. This helps in removal of thrombus along with associated surgical intervention (as in Valve repair). Contrast Echocardiography, TEE and Cardiac MRI are other tests easily available tools for assessment.
Myocardial deformation in hypertensive patients: An analysis using speckle tracking echocardiography R.V. Venkat Rao *, Lanka S.R. Krishna
3-33/45, L. Venkatreddy Colony, Serilingampally, India
Introduction: Speckle tracking echocardiography is an important contributing factor to the systolic function of the left ventricle in health and disease. Evaluation of left ventricular (LV) strain using speckle tracking is a sensitive technique used to assess cardiac performance and can be a better index of systolic function than ejection fraction (EF) in hypertensive patients. We postulate that changes in the myocardial strain, as reflected by longitudinal, radial and circumferential strain, may contribute to LV systolic function in hypertensive patients. Methods: This study evaluated LV myocardial strain in 123 hypertensive patients -41 with EF <50% (HTLEF group) and 41 with EF ≥50% (HTNEF group) with heart failure and 41 with EF >50% and no heart failure (HHD). Subjects were consecutively recruited from cardiac and general medicine and nephrology Clinics from January 2013 to December 2014. Inclusion criteria were: documented prior diagnosis of hypertension (measurements on 3 separate occasions where systolic BP was ≥140 mmHg or diastolic BP was ≥90 mmHg taken over a period of 2 months at the Hypertension Clinic), documented HF using Framingham Study criteria, sinus rhythm and normal coronary angiography. Myocardial strain imaging was acquired using 2D transthoracic imaging and analysed off line using QLab software (Phillips). Introduction: Restrictive Cardiomyopathy (RCM) is a well known entity characterized by progressive diastolic and subsequently systolic biventricular dysfunction. Of the specific causes of RCM, infiltrative disorders are easily recognizable and have specific characteristics. Amyloidosis tops the list among infiltrative disorders presenting as RCM. We report a series of 7 patients with amyloidotic and non amyloidotic infiltrative cardiomyopathies, their presentation, diagnosis and implications in the management. Case series report: Our series includes 7 patients (5 patients were males and 2 were females, with age of 46-58 years). There was no history of hypertension or diabetes. Only one patient had known multiple myeloma and presented subsequently with heart failure and RCM -AL Amyloidosis. 4 patients were diagnosed elsewhere to have non ischemic dilated cardiomyopathy and 2 other patients were diagnosed with hypertrophic cardiomyopathy. On evaluation, they were diagnosed to be having RCM with possible infiltrative etiology. All had low voltage ECG complexes despite severe Biventricular hypertrophy on the echocardiogram. Echocardiography revealed biventricular hypertrophy, speckled hyperechoic myocardium, thickened inter atrial septum, restrictive pattern of diastolic dysfunction, varying degrees of mitral and tricuspid regurgitation and pulmonary arterial hypertension. Four of them also had severe LV systolic dysfunction with EF of 20-35%. Three patients had reduced global longitudinal strain with ''apical sparing'' and relative preservation of radial and circumferential strain, a feature in favor of amyloidosis. Free light chains (kappa or lambda) were elevated in all. Serum immunoelectrophoresis revealed monoclonal gammopathy in four. Urine Bence Jones protein was elevated in two. All but one had Congo Red positivity on bone marrow; the remaining patient was Congo Red negative even on endomyocardial biopsy. Non amyloidotic light chain deposition disease was diagnosed by exclusion (reports of electron microscopy and immunohistochemistry are awaited). 6 of them had multisystem involvement (renal dysfunction and proteinuria, hepatic dysfunction). Five were initiated on chemotherapy with advice for heart transplantation together with Bone marrow transplantation and chemotherapy (Bortezomib regimens). Four died in 6 months from the time of presentation and 3 are on follow up with results of electron microscopy and immunohistochemistry awaited in one. Conclusion: Cardiac amyloidosis is an underappreciated entity. After our diagnosis of first case of non amyloidotic light chain deposition disease, we have been more systematic in analysing patients diagnosed with RCM. Establishing an etiological diagnosis is very important for initiating appropriate therapy including specific pharmacological measures & has an impact on organ transplantation advice and prognostication.
